Press

Publication date:

Press release title:

HIPRA’s COVID-19 vaccine shows an effective immunological response with no adverse effects in preclinical trials

Publication date:

Press release title:

AEMPS authorizes Phase IIb clinical trial of HIPRA Covid-19 vaccine

Publication date:

Press release title:

HIPRA signs an agreement to supply 50 millions doses of Covid-19 vaccine to Vietnam

Publication date:

Press release title:

HIPRA acquires GoodGut and strengthens its Human Health division

Publication date:

Press release title:

The clinical trial of the HIPRA vaccine against COVID-19 is progressing with the administration of the first doses to humans

Publication date:

Press release title:

HIPRA plans to produce 400 million doses of its SARS-CoV-2 HIPRA vaccine during 2022

Publication date:

Press release title:

HIPRA takes a firm step towards human health with research and manufacture of a COVID-19 vaccine

Publication date:

Press release title:

The Girona Health Region has already analyzed more than 30,000 PCR samples, 16% of which are positive

Publication date:

Press release title:

The collaboration between HIPRA and the health authorities allows over 30,000 PCR tests to be analysed in record time

Publication date:

Press release title:

Transferring part of the coronavirus diagnostic testing process to HIPRA increases the number of samples analyzed per day and reduces response time

Publication date:

Press release title:

The Animal Health Company HIPRA makes its biotechnology facilities and equipment available to the health authorities

Publication date:

Press release title:

El traslado a HIPRA de parte del proceso de las pruebas diagnósticas del coronavirus permite aumentar el número de muestras analizadas por día y reducir el tiempo de respuesta